Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Current lentiviral vector systems (the third generation) generate virus particles using four plasmids and a producer cell line. The rationale behind four plasmids is to enhance safety, as ...

ViroCell manufactured a GMP lentiviral vector for UCL to accelerate research into prevention of relapse in childhood blood cancer UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing ...

Lentiviral transduction is a popular and powerful gene delivery method for downstream applications such as cell line generation, therapeutic model generation and CAR-T research. However, current ...

However, it is often difficult for scientists to ramp up the generation of these vectors to meet their ... from Thermo Fisher Scientific to learn how scientists have used their lentiviral production ...